Project Grant R21TR006289
Award Date 5/1/26
Completion Date 4/30/28
Dollars Obligated $436K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Cambridge, MA 02142, USA
Similar Awards
- Federal Grant Award Summary The Broad Institute of MIT and Harvard received a $315,060 Project Grant from the National Institutes of Health Office of the Director under the Trans-NIH Research Support program (CFDA 93.310), awarded June 10, 2025, with completion targeted for May 31, 2026. The grant supports the development of a cell-type-specific atlas of transcription factor (TF)-element connectivity across human tissues by integrating single-cell and single-nucleus Assay for...
- Federal Project Grant Award Summary The Broad Institute of MIT and Harvard received a $6.7 million Project Grant from the National Human Genome Research Institute (NHGRI) under the Human Genome Research program (CFDA 93.172), awarded September 8, 2025, with a completion date of June 30, 2029. This award supports the continued development and enhancement of SEQR, a freely available, open-source genomic analysis platform designed to advance rare disease discovery. The project addresses the...
- Federal Project Grant Award Summary The Broad Institute of MIT and Harvard received a $118,242 Project Grant from the National Institute of General Medical Sciences under the Biomedical Research and Research Training program (CFDA 93.859) effective September 1, 2025, through August 31, 2027. This award supports fundamental research to develop and validate Group-Transfer Chimeras for Inducing Proximity (GRIPs), a novel proximity-inducing platform designed to advance protein therapeutics beyond...
- Federal Project Grant Award Summary The Broad Institute of MIT and Harvard received a $404,282 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), awarded May 1, 2026, with completion anticipated April 30, 2028. The project focuses on engineering adeno-associated virus (AAV) capsids that maintain transferrin receptor 1 (TFR1)-dependent central nervous...
- Federal Grant Award Summary Capienda Biotech, LLC received a $329,272 Project Grant from the National Center for Advancing Translational Sciences (NCATS, CFDA 93.350) awarded on August 1, 2025, with a completion date of July 31, 2026. The award funds development of a high-throughput kinetic screening instrument designed to accelerate small-molecule drug discovery. Building on Phase I Small Business Innovation Research (SBIR) success, Capienda will upgrade its prototype platform to enable...
- Federal Project Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded The Broad Institute of MIT and Harvard a $481,250 Project Grant on August 1, 2025, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The award supports a two-year research initiative concluding July 31, 2027, focused on advancing prion disease treatment through deep prion protein (PrP) suppression. The project will deliver...
- Federal Project Grant Award Summary Boston Children's Hospital received a $130,680 Project Grant award from the National Human Genome Research Institute (NHGRI) under the Human Genome Research program (CFDA 93.172), effective July 1, 2025 through June 30, 2027. The award supports the development of computational technologies and statistical methods for single-cell functional genomics analysis. The research deliverables include: (1) deep learning computational frameworks to decode epigenetic...
- Federal Project Grant Award Summary The Broad Institute, Inc. received a $1,037,340 Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), effective April 1, 2025 through February 28, 2029. The primary deliverable is the development and establishment of the Musculoskeletal Knowledge Portal (MSKKP), a comprehensive biomedical knowledgebase designed to...
- Federal Grant Award Summary The Broad Institute of MIT and Harvard received a $443,564 Project Grant from the National Cancer Institute under the Cancer Treatment Research program (CFDA 93.395) awarded on September 2, 2025, with completion by August 31, 2027. The award supports the development of a novel cancer immunotherapy platform utilizing engineered commensal skin bacteria to stimulate tumor-specific T cell immunity. The research focuses on leveraging Staphylococcus epidermidis, a naturally...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Broad Institute, Inc. a Project Grant totaling $481,250 under the Allergy and Infectious Diseases Research program (CFDA 93.855) for the period August 1, 2025, through July 31, 2027. The award supports the development of novel antimicrobial compounds based on induced proximity principles. The project involves the design and creation of chimeric molecules that combine binders of...